1. Introduction
===============

A student course is a period marked by intense academic stress as well as independence and separation from parenting supervision ([@b1-epj-10-6981]). During this period, risky behavior of adolescents and young people, especially opportunities for the use of psychotropic substances and illicit drugs will increase ([@b2-epj-10-6981], [@b3-epj-10-6981]). Subsequently, today it is considered as one of the main problems of public health. Based on a National Survey on Drugs Use and Health (NSDUH) report, non-medical use of prescriptions is growing and becoming an important part of the illicit drug use problem among university/college students ([@b4-epj-10-6981]). Because of legality, prescription drugs tend to be more easily available than other illegal drugs ([@b5-epj-10-6981]). Nonmedical use of prescription drugs needs particular attention due to the high degree of abuse potential and numerous ill-health consequences ([@b6-epj-10-6981]). For example, nonmedical consumption of prescription opioids can lead to respiratory suppression and overdose ([@b7-epj-10-6981]). Based on a systematic review, the rates of deaths from prescription opioids have increased worldwide ([@b8-epj-10-6981]). It is important to note that, nonmedical use of prescription drugs among young adults has been linked to intention to use or engage in other substances ([@b9-epj-10-6981]). The examples are psychiatric symptoms, psychiatric disorders and suicidal ideation ([@b10-epj-10-6981]). Many studies have focused on risk and protective factors of illicit drug use among young people. From those, familial support and religious beliefs have been mentioned as protective factors for illicit drug use ([@b11-epj-10-6981], [@b12-epj-10-6981]). Although several studies have examined illicit drug use among university students in Iran, there is limited information about prescription-type drug use among university students. For example, Abbasi-Ghahramanloo indicated that 4.9% of students misused prescription drugs in the last year. Also, there is limited information about the role of familial support and religious beliefs on prescription-type drug use. The goal of the present study was to assess the prevalence of prescription-type opioids, methylphenidate and sedative-hypnotics use and related factors, in a sample of Iranian university students.

2. Material and Methods
=======================

2.1. Participants and procedure
-------------------------------

The present cross-sectional study was conducted in 2016 in Hormozgan using multi stage random sampling. First, the proportion of students in each school was considered as stratum. Then, randomly chosen classes were considered as the clusters. Finally, a number of classes were selected in each school and all of the members of the selected class were recruited. Before asking students to fill out the questionnaire, students were given information on how to fill them out, the anonymity and the objective of the study, and also the voluntary nature of the study, by the research team. Students were asked not to include any personal information on the questionnaires. In the final step, pens with same color were distributed among participants to gain their trust.

2.2. Measures
-------------

### 2.2.1. Risk-taking behaviors

For obtaining information about drug use, students completed a self-administrated questionnaire that was prepared earlier in another study ([@b13-epj-10-6981]). The questions about substance use were prepared based on the World Health Organization Alcohol, Smoking and Substance Involvement Screening Test (WHO ASSIST) in regard to the situation of substance use in Iran. The validity of the mentioned questionnaire had been done by a group of researchers in another study ([@b13-epj-10-6981]). In addition, the validity of the questionnaire was assessed by pre testing the scale among Master of Public Health students. The questions aimed to obtain information on cigarette smoking, hookah use, prescription-type opioid use, methylphenidate and sedative-hypnotic (barbiturates and benzodiazepines) use, illicit drug use, having extramarital sex, as well as demographic information. For different substances and extramarital sex, lifetime, last year and last month intervals were asked from students.

### 2.2.2. Religious beliefs

For measuring religious beliefs, we used Kendler's general religiosity questionnaire ([@b14-epj-10-6981], [@b15-epj-10-6981]). This questionnaire has 5- point scaling: 1= completely disagree, 2= disagree, 3= neutral, 4= agree and 5= completely agree. The lowest and highest scores of this questionnaire are 28 and 140 respectively. It should be noted that higher scores indicate higher religious beliefs. The internal consistency of the scale was estimated to be 0.97.

### 2.2.3. Parental support

For measuring parental support, we used Aneshensel and Sucoff's 13- item scale ([@b16-epj-10-6981]). This questionnaire has 5-point Likert type scaling: 1= completely disagree, 2= disagree, 3= neutral, 4= agree and 5= completely agree. The lowest and highest scores of this questionnaire are 13 and 65 respectively. It should be noted that higher scores indicate higher parental support. An estimated reliability coefficient of 0.86, was computed by Cronbach's Alpha Coefficient.

2.3. Statistical analysis
-------------------------

For assessing the relationship of the prescription-type opioids, methylphenidate, and sedative-hypnotics with other variables, the last year of use was used in the statistical analysis. Chi-square and Fisher's exact tests were used to assess the relationship of qualitative variables with prescription-type opioids, methylphenidate, and sedative-hypnotics status. Independent-samples t-test was performed to compare differences of the means of quantitative variables among prescription-type opioids, methylphenidate, and sedative-hypnotics users and non-users. For assessing the relationship of all related factors with prescription-type opioids, methylphenidate and sedative-hypnotics, binary logistic regression was used for each outcome. All analyses were performed using SPSS version 16 (SPSS Inc., Chicago, Illinois, USA) and the statistically significant level was considered as 0.05.

2.4. Research ethics
--------------------

This study was approved by the Ethics Committee of Hormozgan University of Medical Sciences (Ref. no: HUMS.REC.1394.51). Before distributing the questionnaires, explanations were presented by the research team regarding the purposes of the study and the voluntary nature of the students in the study. Then, written informed consent was obtained. Participants were also asked not to include their personal information in the questionnaire. All the questionnaires were completed anonymously to ensure the confidentiality of participants' information.

3. Results
==========

The mean age of the students was 23.0±4.2 years (range: 18--47). The majority of the sample were male (58.2%) and only 19.8 % of the sample were married. [Table 1](#t1-epj-10-6981){ref-type="table"} presents the percentage of 'Yes' response to the use of prescription-type opioids, methylphenidate and sedative-hypnotics use in different time intervals. It is apparent from this table that among 524 students, 109 (20.8%), 84 (16.1%) and 25 (9.9%) had used prescription-type opioids in their lifetime, past year and past month respectively. This table indicates that the lifetime, past year and past month prevalence of methylphenidate use was found to be 5.4%, 3.3%, and 2.3% respectively. Also, the prevalence of sedative-hypnotics use in the three mentioned time intervals was 15.6, 10.3 and 6.1%. [Table 2](#t2-epj-10-6981){ref-type="table"} presents the demographic characteristics and risk variables of the total sample, as well as the conditional distribution of prescription-type opioids, methylphenidate and sedative-hypnotics use at each level of the variables. Also, the mean and standard deviation of the age of the students, the score of familial support and score of religious beliefs were presented in this table.

[Table 3](#t3-epj-10-6981){ref-type="table"} shows the results of the binary logistic regression. This table indicates that living in a dormitory (OR=0.50) and single house (OR=0.07) in comparison to a parental home, last year hookah use (OR=2.5), last year methylphenidate use (OR=4.5), last year sedative-hypnotics use (OR=2.7) and having higher score of familial support (OR=0.97) were factors associated with students' prescription-type opioid use. After adjusting for other factors, results of the final analysis indicate that last year sedative-hypnotics use (OR=5.7) and lifetime illicit drug use (OR=27.6) were associated with students' methylphenidate use. Also, past year hookah use (OR=4.9), last year prescription-type opioids (OR=2.2) and last year methylphenidate use (OR=7.5) were associated with sedative-hypnotics.

4. Discussion
=============

In the present study, the lifetime, past year and past month prevalence of prescription-type opioid use were determined to be 20.8%, 16.1%, and 9.9% respectively. According to the 2016 world drug report, it was estimated that in 2014, the annual prevalence of opioid use among the population aged 15--64 was 0.7 and 0.42% in the world and Asia respectively ([@b14-epj-10-6981]). In the United States, based on National Survey on Drug Use and Health (NSDUH) data among people aged 18--25 years old, the lifetime, past year and past month prevalence of use of prescription opioids were 18.2, 9.6 and 3.6% respectively in 2001 ([@b6-epj-10-6981]). However, in 2015, the prevalence of using prescription opioids in the last year was 37.8%. Also in the last year, 4.7% of participants misused prescription opioids and 0.8% reported having use disorder ([@b17-epj-10-6981]). In the latest Monitoring The Future (MTF) study ([@b18-epj-10-6981]), lifetime, past year and past month prevalence of narcotics other than heroin (including methadone, morphine, codeine, etc.) were 6.6, 3.3 and 1.3%. A national study from Iran indicated that 49.3% of Iranian adults had used this type of drug at least once in the last year in 2014 ([@b19-epj-10-6981]). Some previous studies from Iran reported the separated prevalence of each non-medical use of opioid drugs among university students. For example, the prevalence of last month morphine use had been reported as 0.36% among Gilan University of Medical Sciences (Gilan Province, Iran) ([@b20-epj-10-6981]). Another study from Hamadan showed that 9.5% of college students had used tramadol in the last month ([@b21-epj-10-6981]). Overall, it seems that the prevalence of using prescription-type opioids is high among Iranian students. Some differences among results of studies can be attributed to the definition of prescription opioids and the place of study. Also in Iran, in comparison to illicit drugs, prescription opioids have a low social stigma.

Results from the present study also indicated that the lifetime, past year and past month prevalence methylphenidate use was 5.4, 3.3 and 2.3%. In a Monitoring The Future (MTF) study in the US, 2% of the participants had used methylphenidate in the past year in 2015 ([@b18-epj-10-6981]). A qualitative study among university students in Tehran (capital of Iran) showed that unlike other drugs that are used recreationally, methylphenidate is used for enhancing learning abilities and academic achievements. This drug can be easily used and is considered to be stigma free ([@b22-epj-10-6981]). A smaller study among medical students from Iran showed that 8.7 % of the participants had used methylphenidate at least once in their lifetime ([@b23-epj-10-6981]). Another study among residents of clinical specialties of Tehran University of Medical Sciences indicated that lifetime, past year and past month prevalence of methylphenidate use was 48%, 23% and 6.6% respectively ([@b24-epj-10-6981]). It seems that there is no negative attitude toward methylphenidate use among some of the medical university students. For example, Khademi and Shariat showed that 20% of the residents had a positive attitude toward methylphenidate ([@b24-epj-10-6981]). This can be seen as a warning of the start of a methylphenidate use epidemic among young people in Iranian universities. In this study, the prevalence of sedative-hypnotics use in a lifetime, past year and past month was obtained to be 15.6, 10.3 and 6.1% respectively. In an MTF study ([@b18-epj-10-6981]), non-prescription use of sedatives in a lifetime, last year and last month was reported to be 4.4%, 2.3% and 1% in 2015. This study also indicated that the prevalence of tranquilizers in the three mentioned time intervals were reported to be 7.8%, 4.3%, and 1.6% respectively. Regarding European countries, in a recent European School Survey Project on Alcohol and Other Drug (ESPAD) study ([@b25-epj-10-6981]), it was found that on average, 6% of the students reported lifetime non-medical use of tranquilizers or sedatives, ranging from the lowest (2%) in Moldova to the highest (17%) in Poland. Due to the different definitions of the sedative-hypnotics, the best comparisons are not possible. But the rates of this drug usage in this study seem to be high and needs attention.

One of the effective approaches in drug-related research is considering the co-occurrence nature of these behaviours. Some prior studies were able to show co-occurrence of risky behaviours ([@b26-epj-10-6981]--[@b28-epj-10-6981]). Our findings indicated that prescription-type opioids, methylphenidate, and sedative-hypnotics use are strongly associated with each other as well as all risk taking behaviours. Brooks at al. emphasized that involvement in one risky behaviour is related to engagement in other risky behaviours ([@b29-epj-10-6981]). Co-occurrence of high risk behaviours in our study further highlights the importance of implementing co-morbid substance use prevention programs among university students. Numerous researches have pointed to the inhibiting role of religious beliefs and familial support in engaging in high risk behaviours ([@b15-epj-10-6981], [@b30-epj-10-6981]--[@b32-epj-10-6981]). The result of the present study indicated that the mean score of religious beliefs was significantly associated with prescription-type opioid use. Also, the mean score of familial support was significantly associated with prescription-type opioids, methylphenidate and sedative-hypnotics use. However, only the mean score of familial support remains significant for the prescription-type opioid use in the logistic model.

5. Limitations
==============

The limitations of this study were: 1) causality could not be assessed due to the cross sectional nature of the study design, and 2) underreporting of drug use could not be ruled out because the study relied on self-report data.

6. Conclusions
==============

In this study, we present the prevalence of non-medical use of prescription-type opioids, methylphenidate, and sedative-hypnotics, and determined some of related factors. Overall, our findings suggest that the prevalence of prescription type drug use is considerably high among our study samples. For exact estimations and determining the affecting factors, longitudinal studies are required. The results of the present study can be used for planning and evaluating interventions among Hormozgan medical university sciences by considering the protective and risk factors.
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###### 

Prevalence of Prescription-type opioids, Methylphenidate and Sedative-hypnotics by gender.

  Variable                    Male [\*](#tfn1-epj-10-6981){ref-type="table-fn"}   Female [\*](#tfn1-epj-10-6981){ref-type="table-fn"}   Total [\*](#tfn1-epj-10-6981){ref-type="table-fn"}   
  --------------------------- --------------------------------------------------- ----------------------------------------------------- ---------------------------------------------------- ------------
  Prescription-type opioids   Lifetime use                                        59 (27.4)                                             49 (16.1)                                            109 (20.8)
  Last year use               45 (20.9)                                           38 (12.5)                                             84 (16.1)                                            
  Last month use              26 (12.1)                                           25 (8.2)                                              52 (9.9)                                             
  Methylphenidate             Lifetime use                                        17 (7.9)                                              11 (3.6)                                             28 (5.4)
  Last year use               11 (5.1)                                            6 (2.0)                                               17 (3.3)                                             
  Last month use              8 (3.7)                                             4 (1.3)                                               12 (2.3)                                             
  Sedative-hypnotics          Lifetime use                                        44 (20.5)                                             38 (12.5)                                            82 (15.6)
  Last year use               27 (12.6)                                           27 (8.9)                                              54 (10.3)                                            
  Last month use              15 (7.0)                                            17 (5.6)                                              32 (6.1)                                             

Data are presented as n (%)

###### 

Demographic characteristics and correlated variables by last year use of "prescription-type opioids", "Methylphenidate", and "Sedative-hypnotics" in a sample of Iranian students in 2016.

  Characteristics                         Prescription-type opioids   Methylphenidate   Sedative-hypnotics                                          
  --------------------------------------- --------------------------- ----------------- -------------------- ---------- --------------- ----------- ---------
  Gender                                  Male                        38 (12.5)         0.010                6 (2.0)    0.046           27 (8.9)    0.177
  Female                                  45 (20.9)                                     11 (5.1)                        27 (12.6)                   
  Marital status                          Single                      63 (15.3)         0.458                12 (2.9)   0.331           42 (10.2)   0.903
  Married                                 19 (18.3)                                     5 (4.8)                         11 (10.6)                   
  Living in                               Parental home               26 (21.0)         0.297                2 (1.6)    0.042           11 (8.9)    \<0.001
  Dormitory                               50 (13.7)                                     11 (3.0)                        31 (8.4)                    
  Single house                            6 (21.4)                                      3 (10.7)                        11 (39.3)                   
  Smoking (last year)                     No                          61 (13.7)         \<0.001              7 (1.6)    \<0.001         33 (7.4)    \<0.001
  Yes                                     23 (30.3)                                     10 (13.2)                       21 (27.6)                   
  Hookah use (last year)                  No                          49 (12.0)         \<0.001              6 (1.5)    \<0.001         24 (5.9)    \<0.001
  Yes                                     35 (30.4)                                     11 (9.5)                        30 (25.9)                   
  Alcohol use (last year)                 No                          63 (13.9)         \<0.001              7 (1.5)    \<0.001         34 (7.5)    \<0.001
  Yes                                     21 (31.3)                                     10 (14.7)                       20 (29.4)                   
  Prescription-type opioids (last year)   No                          \-                \-                   7 (1.6)    \<0.001         32(7.3)     \<0.001
  Yes                                     \-                                            10 (11.9)                       22 (26.2)                   
  Methylphenidate (last year)             No                          74 (14.7)         \<0.001              \-         \-              42 (8.3)    \<0.001
  Yes                                     10 (58.8)                                     \-                              12 (70.6)                   
  Sedative-hypnotics (last year           No                          62 (13.3)         \<0.001              5 (1.1)    \<0.001         \-          \-
  Yes                                     22 (40.7)                                     12 (22.2)                       \-                          
  Illicit drugs                           No                          62 (13.4)         \<0.001              3 (0.6)    \<0.001         32 (6.9)    \<0.001
  Yes                                     21 (41.2)                                     13 (25.5)                       21 (41.2)                   
  Extra marital sex(last year)            No                          66 (14.2)         \<0.001              8 (1.7)    \<0.001         41 (8.8)    0.001
  Yes                                     17 (34.7)                                     8 (16.3)                        12 (24.5)                   
  Age (year); Mean (SD)                   23.7 (4.6)                  0.08              24.6 (4.44)          0.09       24.0 (4.9)      0.06        
  Score of religious beliefs; Mean (SD)   113.3 (20.0)                0.014             121.5 (16.3)         0.455      115.0 (18.02)   0.204       
  Score of familial support; Mean (SD)    50.1 (9.6)                  \<0.001           45.4 (14.6)          0.001      50.3 (11.1)     0.005       

###### 

Logistic regression analysis of the association between last year use of "prescription-type opioids", "Methylphenidate" and "Sedative-hypnotics" and their correlated factors in a sample of Iranian students 2016

  Variables                              Prescription-type opioids[a](#tfn2-epj-10-6981){ref-type="table-fn"}   Methylphenidate[b](#tfn3-epj-10-6981){ref-type="table-fn"}   Sedative-hypnotics[c](#tfn4-epj-10-6981){ref-type="table-fn"}                                                              
  -------------------------------------- ---------------------------------------------------------------------- ------------------------------------------------------------ --------------------------------------------------------------- ------ ------------ --------- ----- ------------ --------- ----
  Living in                              Parental home                                                          Ref                                                          \-                                                              \-     \-           \-        \-    \-           \-        \-
  Dormitory                              0.50                                                                   0.27--0.92                                                   0.027                                                           \-     \-           \-        \-    \-           \-        
  Single house                           0.07                                                                   0.008--0.72                                                  0.075                                                           \-     \-           \-        \-    \-           \-        
  Hookah use (last year)                 2.5                                                                    1.3--4.7                                                     0.005                                                           \-     \-           \-        4.9   2.4--9.8     \<0.001   
  Prescription-type opioids(last year)   \-                                                                     \-                                                           \-                                                              \-     \-           \-        2.2   1.01--5.03   0.046     
  Methylphenidate (last year)            4.5                                                                    1.0--18.8                                                    0.040                                                           \-     \-           \-        7.5   1.9--30.2    0.004     
  Sedative-hypnotics (last year)         2.7                                                                    1.2--6.2                                                     0.019                                                           5.7    1.4--23.2    0.016     \-    \-           \-        
  Illicit drugs (life time)              \-                                                                     \-                                                           \-                                                              27.6   6.4--118.6   \<0.001   \-    \-           \-        
  Familial support                       0.97                                                                   0.94--0.99                                                   0.037                                                           \-     \-           \-        \-    \-           \-        

Variables entered on step 1: gender, age, marital status, living place, smoking, hookah use, alcohol use, methylphenidate, sedative-hypnotics, illicit drug use, extra marital sex, religious beliefs and familial support.

Variables entered on step 1: gender, age, marital status, living place, smoking, hookah use, alcohol use, prescription-type opioids, sedative-hypnotics, illicit drug use, extra marital sex, religious beliefs and familial support.

Variables entered on step 1: gender, age, marital status, living place, smoking, hookah use, alcohol use, prescription-type opioids, methylphenidate, illicit drug use, extra marital sex, religious beliefs and familial support.
